Record title
Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study
Record identifier
TN_cdi_doaj_primary_oai_doaj_org_article_818a83d218a2459181cd108eadde6c2e
Record permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_818a83d218a2459181cd108eadde6c2e
Share
Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study
About this item
Full title
Safety and efficacy of SHR4640 combined with febuxostat for primary hyperuricemia: a multicenter, randomized, double-blind, phase II study
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Therapeutic advances in musculoskeletal disease, 2022, Vol.14, p.1759720X211067304-1759720X211067304
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_818a83d218a2459181cd108eadde6c2e
Language
English
Formats
Publication information
Publisher
Subjects
More information
Scope and Contents
Contents
Alternative Titles
Full title
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_818a83d218a2459181cd108eadde6c2e
Permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_818a83d218a2459181cd108eadde6c2e
Other Identifiers
ISSN
E-ISSN
DOI
